Tag Archives: liver damage

Paracetamol deaths falling

Deaths from paracetamol overdoses fell by 43% in England and Wales in the 11 years after the law on pack sizes was changed, according to a study.

But the number of people taking paracetamol overdoses had not declined, says the Oxford University study published in the BMJ.

In 1998, the government restricted pack sizes in the UK to 32 tablets in pharmacies and 16 in other shops.

Researchers say the figures should not lead to “complacency”.

Paracetamol overdoses are a common method of suicide and a frequent cause of liver damage.

Previous studies suggested the decision to restrict the size of packs of paracetamol sold over the counter showed initial benefits in both these areas, but there was no data on the long-term impact.

Using figures from the Office for National Statistics, the Oxford researchers looked at deaths involving paracetamol in people aged 10 years and over between 1993 and 2009.

They found there were fewer deaths after the legislation was introduced in 1998 than would have been predicted based on trends dating back to 1993.

Paracetamol

Paracetamol

The study also found that patients registered for a liver transplant because of a paracetamol overdose had reduced by 61% following the legislation. This was equivalent to 482 fewer registrations over 11 years.

Prof Keith Hawton, lead researcher from the University of Oxford Centre for Suicide Research, said lives had been saved since the change in the law.


“While some of this effect could have been due to improved hospital management of paracetamol overdoses, we believe that this has in large part been due to the introduction of the legislation.

“We are extremely pleased that this measure has had such benefits, but think that more needs to be done to reduce the toll of deaths from this cause.”

Despite the reduction in deaths from paracetamol, the study found there had been no decline in overdose cases after 1998.

The study added that additional measures would be needed to reduce the death toll, such as lowering the limit on tablets in packs further, reducing the paracetamol content of the tablets and enforcing the legislation more effectively.

Popular diet drug dangers

Dieters have been warned that using a popular over-the-counter slimming pill could put them at risk of severe organ damage.

A U.S. study has claimed that taking Alli, which helps to block the absorption of fat from food, impacts on a key enzyme within the body and could lead to ‘severe toxicity of internal organs such as the liver and kidney’.

Researchers have also claimed the weight-loss aid hampers the effectiveness of medicines including some anti-cancer drugs.

Rhode Island University’s Professor Bingfang Yan, who led the study, has said there has been a ‘drastic increase in toxicity’ among people using Alli since it was made available over the counter.

According to a report in the Daily Express, the professor said Orlistat – Alli’s active ingredient – inhibits carboxylesterase-2, an enzyme he said works to detoxify the liver, kidney and gastrointestinal tract.

Diet drug Alli

Diet drug Alli

‘When the activity of this enzyme drops in those organs, toxicity increases or the efficacy of some drugs is altered,’ said Professor Yan.

He said the enzyme’s ability to metabolise a wide range of medicines, and that the effectiveness of those medicines – in particular a number of anti-cancer drugs – was at risk of being ‘weakened’ by the use of Orlistat.


GlaxoSmithKline, which makes the slimming aid, has strongly refuted any suggestion that Alli is unsafe.

‘Earlier this year the European regulator reaffirmed the safety profile of Orlistat following a review of the medicine and possible side-effects,’ a spokesman said.

The drugs giant also said the results of the U.S. study, which was published in the Biochemical Pharmacology journal, were based on laboratory tests rather than tests on humans, and were inconsistent with data gathered from patients treated with Orlistat.

Alli triggered massive sales when it was launched in the UK in 2009 – £1million worth of the pills were sold on the first day.